Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Abstract
Significantly, much of the activity of Citrus flavonoids appears to impact blood and microvascular endothelial cells, and it is not surprising that the two main areas of research on the biological actions of Citrus flavonoids have been inflammation and cancer. Epidemiological and animal studies point to a possible protective effect of flavonoids against cardiovascular diseases and some types of cancer. Although flavonoids have been studied for about 50 years, the cellular mechanisms involved in their biological action are still not completely known. Many of the pharmacological properties of Citrus flavonoids can be linked to the abilities of these compounds to inhibit enzymes involved in cell activation. Attempts to control cancer involve a variety of means, including the use of suppressing, blocking, and transforming agents. Suppressing agents prevent the formation of new cancers from procarcinogens, and blocking agents prevent carcinogenic compounds from reaching critical initiation sites, while transformation agents act to facilitate the metabolism of carcinogenic components into less toxic materials or prevent their biological actions. Flavonoids can act as all three types of agent. Many epidemiological studies have shown that regular flavonoid intake is associated with a reduced risk of cardiovascular diseases. In coronary heart disease, the protective effects of flavonoids include mainly antithrombotic, anti-ischemic, anti-oxidant, and vasorelaxant. It is suggested that flavonoids decrease the risk of coronary heart disease by three major actions: improving coronary vasodilatation, decreasing the ability of platelets in the blood to clot, and preventing low-density lipoproteins (LDLs) from oxidizing. The anti-inflammatory properties of the Citrus flavonoids have also been studied. Several key studies have shown that the anti-inflammatory properties of Citrus flavonoids are due to its inhibition of the synthesis and biological activities of different pro-inflammatory mediators, mainly the arachidonic acid derivatives, prostaglandins E 2, F 2, and thromboxane A 2. The anti-oxidant and anti-inflammatory properties of Citrus flavonoids can play a key role in their activity against several degenerative diseases and particularly brain diseases. The most abundant Citrus flavonoids are flavanones, such as hesperidin, naringin, or neohesperidin. However, generally, the flavones, such as diosmin, apigenin, or luteolin, exhibit higher biological activity, even though they occur in much lower concentrations. Diosmin and rutin have a demonstrated activity as a venotonic agent and are present in several pharmaceutical products. Apigenin and their glucosides have been shown a good anti-inflammatory activity without the side effects of other anti-inflammatory products. In this paper, we discuss the relation between each structural factor of Citrus flavonoids and the anticancer, anti-inflammatory, and cardiovascular protection activity of Citrus flavonoids and their role in degenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance
Bravo, L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01670.x · Cited by 4,030
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Research works printed but not linked: 26
- Bär A., 1990, Food Sci. Technol., 23, 371
- Yañez J., 2002, Oncologia, 25, 210
- Martínez C., 2001, Rev. Esp. Patol., 34, 317
- Benavente-García O., 2005, Agro Food Ind. Hi-Tech, 4, 30
- Fotsis T., 1997, Cancer Res., 57, 2916
- Kawaii S., 1999, Anticancer Res., 19, 1261
- Kandaswami C., 2005, In Vivo, 19, 895
- Ohno T., 2001, Anticancer Res., 21, 3875
- Caltagirone S., 2000, J. Cancer, 87, 595
- Czyz J., 2004, Cancer Cell Biol., 114, 12
- Tanaka T., 2000, Cancer Res., 60, 3713
- Yoshikawa N., 2001, In Vivo, 15, 485
- Zhu Y., 2001, Int. J. Oncol., 18, 1299
- Tanaka T., 1997, Cancer Res., 57, 246
- Cova D., 1992, Int. J. Clin. Pharmacol. Ther. Toxicol., 30, 29
- Guerrero J. A., 2005, Thromb. Haemostasis, 2, 1
- Woodhouse E. C., 1997, Cancer, 80, 1529, 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F · DOI · Paper page
- Szatrowsky T. P., 1991, Cancer Res., 51, 794
- Masferrer J. L., 2000, Cancer Res., 60, 1306
- Fotsis T., 1997, Cancer Res., 57, 2916
- Guzik T. J., 2000, Circ. Res., 86, E85
- Shono T., 1996, Mol. Cell. Biol., 16, 4231, 10.1128/MCB.16.8.4231 · DOI · Paper page
- Olszanecki R., 2002, J. Physiol. Pharmacol., 53, 571
- Monforte M. T., 1995, Pharmacology, 50, 595
- Middleton E., 2000, Pharmacol. Rev., 52, 673, 10.1016/S0031-6997(24)01472-8 · DOI · Paper page
- Schubert P., 1998, J. Neural Transm., 54, 167
Cited by
Phenolic composition, antioxidant potential and health benefits of citrus peel
Singh, B., Singh, J. P., Kaur, A., & Singh, N. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109114 · Cited by 711
History, Global Distribution, and Nutritional Importance of Citrus Fruits
Liu, Y., Heying, E., & Tanumihardjo, S. A. (2012) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2012.00201.x · Cited by 671
Anticancer potential of quercetin: A comprehensive review
Rauf, A., Imran, M., Khan, I. A., ur‐Rehman, M., Gilani, S. A., Mehmood, Z., & Mubarak, M. S. (2018) · Phytotherapy Research · doi:10.1002/ptr.6155 · Cited by 654
Converting citrus wastes into value-added products: Economic and environmently friendly approaches
Sharma, K., Mahato, N., Cho, M. H., & Lee, Y. R. (2017) · Nutrition · doi:10.1016/j.nut.2016.09.006 · Cited by 617
Citrus peel as a source of functional ingredient: A review
Rafiq, S., Kaul, R., Sofi, S. A., Bashir, N., Nazir, F., & Ahmad Nayik, G. (2018) · Journal of the Saudi Society of Agricultural Sciences · doi:10.1016/j.jssas.2016.07.006 · Cited by 581
Metadata
- Authors
- Benavente-García, O., & Castillo, J.
- Affiliations
- Universidad de Murcia (ES)
- Corresponding author
- Benavente-García, O.
- ORCID
- Castillo, J.
- Venue
- Journal of Agricultural and Food Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-07-02
- Volume
- 56
- Issue
- 15
- Pages
- 6185-6205
- ISSN
- 0021-8561 (ISSN-L)
- 1520-5118
- OpenAlex
- W1991774590
- Cited by
- 1,158
- References
- 196
- Citations by year
- 2026: 33 · 2025: 42 · 2024: 63 · 2023: 60 · 2022: 85 · 2021: 74 · 2020: 80 · 2019: 83 · 2018: 80 · 2017: 81 · 2016: 60 · 2015: 82 · 2014: 75 · 2013: 59 · 2012: 73
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Agricultural and Food Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Bioactive Compounds in Plants
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
- Keywords
- citrus flavonoids, flavonoids, anticancer activity, cardiovascular disease, anti-inflammatory activity, coronary artery disease, endothelial cells, flavanones, flavones, hesperidin, naringin, diosmin, rutin, apigenin, luteolin, LDL oxidation, platelet aggregation, prostaglandins, thromboxane
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cardiovascular Diseases, Cell Division, Citrus, Flavonoids, Humans, Neoplasm Invasiveness, Neoplasms, Neovascularization, Pathologic, Anticarcinogenic Agents, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.